Event Brings Together Industry Leaders in Clinical Trials
NEW YORK--(BUSINESS WIRE)--Nov. 28, 2017--
(NASDAQ:MDSO), the leading global provider of cloud-based technology and
data analytics for clinical research, announced that Anthony Costello,
vice president of mobile health, and Michael Hughes, lead product
manager for payments at the Company, will speak at the 2017 Partnerships
in Clinical Trials Europe (PCT) conference; which is taking place from
November 28-29 at the RAI Exhibition and Convention Centre in Amsterdam.
The PCT annual conference unites over 1,000 stakeholders from across the
clinical spectrum to share expert knowledge on improving clinical
strategies. Since 2001, the conference has brought together leaders from
the industry to provoke change and foster solutions that advance
clinical trial collaborations. This year’s event will focus on
accelerating clinical development and improving trial benchmarking,
enhancing clinical practices and partnering to bring patients to the
forefront in clinical trials.
Michael Hughes will moderate a panel on cost savings associated with an
integrated budget-to-payments solution. The session, which will take
place at 12:00 pm on November 28, will highlight a number of areas
including payment challenges, end-to-end payment solutions, data entry
elimination and traceability. Michael will be joined by representatives
from Amgen, INC Research and VivMedical.
Anthony Costello will participate in a panel during the plenary session
and discuss the advances of mobile and clinical technology, including
the impact on clinical research and existing barriers. The session,
which will take place at 9:40 am on November 29, will look into the
future of technology, mHealth, wearables and innovation for clinical
trials, new innovation integrations into CRO partnerships, consumer
devices and more. The session will be chaired by Bruce Hellman, CEO of
uMotif, and will include representatives from Radboud University Medical
Center, ICON and AstraZeneca.
Medidata will also showcase its industry leading unified cloud platform
through demonstrations of Medidata
Clinical Cloud®, Rave®,
Christian Hebenstreit, general manager & senior vice president EMEA,
“At Medidata we are constantly evolving our technologies to improve and
revolutionize clinical trial practices. Partnerships in Clinical Trials
Europe is an important event that brings together leading experts across
the clinical trials space to address challenges and drive change.”
Further details can be found on the PCT conference website.
is reinventing global drug and medical device development by creating
the industry's leading cloud-based solutions for clinical research.
Through our advanced applications and intelligent data analytics,
Medidata helps advance the scientific goals of life sciences customers
worldwide, including over 950 global pharmaceutical companies, biotech,
diagnostic and device firms, leading academic medical centers, and
contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality and
efficiency to clinical trials that empower our customers to make more
informed decisions earlier and faster. Our unparalleled clinical trial
data assets provide deep insights that pave the way for future growth.
The Medidata Clinical Cloud is the primary technology solution powering
clinical trials for 18 of the world's top 25 global pharmaceutical
companies and is used by 18 of the top 25 medical device developers—from
study design and planning through execution, management and reporting.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171127005741/en/
Erik Snider, +1-646-362-2997